HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Research analysts at Roth Capital raised their Q4 2026 earnings per share estimates for shares of HIVE Blockchain Technologies in a research report issued on Monday, January 6th. Roth Capital analyst D. Aftahi now expects that the company will earn $0.04 per share for the quarter, up from their previous estimate of $0.03. Roth Capital has a “Strong-Buy” rating on the stock.
Several other analysts have also recently weighed in on HIV. Cantor Fitzgerald raised HIVE Blockchain Technologies to a “strong-buy” rating in a report on Tuesday, October 29th. Northland Capmk upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a report on Thursday, September 19th.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Recommended Stories
- Five stocks we like better than HIVE Blockchain Technologies
- Most active stocks: Dollar volume vs share volume
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Insider Trading – What You Need to Know
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
